This site is intended for UK healthcare professionals

 
Sponsorship statement:
Novartis Pharmaceuticals UK Ltd has provided OmniaMed Communications Ltd with an arm’s-length sponsorship towards the development of the British Journal of Cardiology masterclasses.
novartis-logo-transparent

Masterclass: Treating dyslipidaemia – special populations

8 August 2024
Available for 1 CPD point(s)

Masterclass

In this masterclass, Alison Pottle and Jai Cegla provide discuss screening for familial hypercholesterolaemia (FH), treatment advances in dyslipidaemia, the role of lipid apheresis in specific populations and the importance of patient education.

Speakers

Alison Pottle Consultant Nurse in Cardiology, Harefield Hospital, UK
Jai Cegla Consultant in Chemical Pathology and Metabolic Medicine, Imperial College Healthcare NHS Trust, UK 

Learning objectives

    • To discuss the available tools and potential barriers to screening for FH

    • To provide an overview of the recent advances in treatment for dyslipidaemia

    • To discuss the role of lipid apheresis in treating people with homozygous FH

    • To outline key discussion points to raise with people with dyslipidaemia

    Learning module instructions

    This BJC TV Learning module has a recommended award of 1 CPD credit for completion (1 hour of learning).
    Completion requires a score of at least 80%. If less time is spent learning, then you should claim a reduced credit value.
    After you have successfully completed the test you will be able to download your certificate.

    References

    1. NICE (2019) Familial hypercholesterolaemia: identification and management [CG71]. Available at: https://www.nice.org.uk/guidance/cg71 (accessed August 2024)

    2. Morrell J. Br J Cardiol 2008;15:79–81.

    3. Public Health England (2018) Familial Hypercholesterolaemia – Implementing a systems approach to detection and management. Available at: https://assets.publishing.service.gov.uk/media/5b646bbced915d37793abcda/familial_hypercholesterolaemia_implementation_guide.pdf (accessed August 2024).

    4. Benn M et al. Eur Heart J. 2016;37:1384–1394.

    5. Mach F et al. Eur Heart J. 2020;41:111–188.

     

    Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.